InsidersTradesSigma
Browse the complete record of transactions filed by Calabrese Salvatore, Chief Financial Officer. Officer active across 1 companies, notably Gain Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €23m. The latest transaction was filed on 19 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Calabrese Salvatore is the Chief Financial Officer of Gain Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health of the company and supporting its growth initiatives.